Liver cancer cases and deaths projected to rise by more than 55% by 2040
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of…
Jhep
Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for…
Call for applications for the roles of chair of two new Clinical Practice Guidelines on the liver involvement in systemic infections and in inflammatory systemic diseases
EASL has launched several highly influential Clinical Practice Guidelines (CPGs). The objective of these CPGs is to provide simple, clear, and evidence-based guidelines that can be used for patient management and reimbursement policies all over Europe. EASL CPGs have become a global reference, pr…
Journal of Hepatology impact factor ranking climbs again, remaining leader among specialist hepatology journals
ClarivateTM Analytics released the 2022 update of its Journal Citation Reports©, including the much anticipated 2021 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2021 impact factor of 30.083, up from the 2020 score of 25.083. Gen…
New EASL CPGs provide guidance on haemochromatosis
1 June 2022 EASL is proud to announce the release of EASL Clinical Practice Guidelines on Haemochromatosis, just published in the Journal of Hepatology. This marks World Haemochromatosis Week taking place every year in the first week of June. The Panel was chaired by Heinz Zoller. Panel members…
New EASL CPGs provide guidance on preventing and managing bleeding and thrombosis in patients with cirrhosis
15 March 2022 EASL is proud to announce the release of new set of EASL Clinical Practice Guidelines (CPGs) on the prevention and management of bleeding and thrombosis in patients with cirrhosis, addressing the difficult clinical questions posed by the occurrence of both bleeding and thrombosis. A…
Initiative to map the Cholangiocarcinoma landscape in Europe will help improve patient outcomes
Scientists advocate for education programmes to raise awareness and improve early diagnosis, survival, and quality of life of cholangiocarcinoma (CCA) patients in the largest and most complete multicentre study of CCA, published in the Journal of Hepatology. Amsterdam, February 12, 2022 – Bile du…
New study shows link between long-term exposure to air pollution and liver disease
A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and metabolic-associated fatty liver disease (MAFLD), report scientists in the Journal of Hepatology. Amsterdam, December 6, 2021 – Metabolic-associated fatty liver disease (MAFLD) …
Journal of Hepatology ranking soars, remaining the leader among specialist hepatology journals
ClarivateTM Analytics released the 2021 update of its Journal Citation Reports©, including the much anticipated 2020 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2020 impact factor of 25.083, up from the 2019 score of 20.582. Gen…
Patients with cirrhosis at increased risk of death from COVID-19, study finds
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October 6, 2020 – The study, published in the Journal of Hepatology found that mortality from COVID-…